Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multimeric Epitope-Scaffold HIV Vaccines Target V1V2 and Differentially Tune Polyfunctional Antibody Responses
Ann J. Hessell, Rebecca Powell, Xunqing Jiang, et al.
Cell Reports (2019) Vol. 28, Iss. 4, pp. 877-895.e6
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Potent transmission-blocking monoclonal antibodies from naturally exposed individuals target a conserved epitope on Plasmodium falciparum Pfs230
Danton Ivanochko, Amanda Fabra-García, Karina Teelen, et al.
Immunity (2023) Vol. 56, Iss. 2, pp. 420-432.e7
Open Access | Times Cited: 19
A Pentavalent HIV-1 Subtype C Vaccine Containing Computationally Selected gp120 Strains Improves the Breadth of V1V2 Region Responses
Xiaoying Shen, Bette Korber, Rachel L. Spreng, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 133-133
Open Access
Vaccine-induced V1V2-specific antibodies control and or protect against infection with HIV, SIV and SHIV
Susan Zolla‐Pazner, Raymond A Alvarez, Xiang‐Peng Kong, et al.
Current Opinion in HIV and AIDS (2019) Vol. 14, Iss. 4, pp. 309-317
Open Access | Times Cited: 34
A High-Throughput Assay for Circulating Antibodies Directed Against the S Protein of Severe Acute Respiratory Syndrome Coronavirus 2
Svenja Weiß, Jéromine Klingler, Catarina E. Hioe, et al.
The Journal of Infectious Diseases (2020) Vol. 222, Iss. 10, pp. 1629-1634
Open Access | Times Cited: 30
V2-Directed Vaccine-like Antibodies from HIV-1 Infection Identify an Additional K169-Binding Light Chain Motif with Broad ADCC Activity
Charmaine van Eeden, Constantinos Kurt Wibmer, Cathrine Scheepers, et al.
Cell Reports (2018) Vol. 25, Iss. 11, pp. 3123-3135.e6
Open Access | Times Cited: 28
The V2 loop of HIV gp120 delivers costimulatory signals to CD4+T cells through Integrin α4β7and promotes cellular activation and infection
Lívia R. Góes, Alia Sajani, Aida Sivro, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 51, pp. 32566-32573
Open Access | Times Cited: 20
Outsmarting Pathogens with Antibody Engineering
Ahlam N. Qerqez, Rui P. Silva, Jennifer A. Maynard
Annual Review of Chemical and Biomolecular Engineering (2023) Vol. 14, Iss. 1, pp. 217-241
Open Access | Times Cited: 6
Structure-Based and Rational Design of a Hepatitis C Virus Vaccine
Johnathan D. Guest, Brian G. Pierce
Viruses (2021) Vol. 13, Iss. 5, pp. 837-837
Open Access | Times Cited: 15
Short Carbon Nanotube-Based Delivery of mRNA for HIV-1 Vaccines
Yang Xu, Tammy Ferguson, Kazuya Masuda, et al.
Biomolecules (2023) Vol. 13, Iss. 7, pp. 1088-1088
Open Access | Times Cited: 5
V2-Specific Antibodies in HIV-1 Vaccine Research and Natural Infection: Controllers or Surrogate Markers
Ralf Duerr, Miroslaw K. Górny
Vaccines (2019) Vol. 7, Iss. 3, pp. 82-82
Open Access | Times Cited: 16
Recent insights into Fc-mediated effector responses to HIV-1
Margaret C. Carpenter, Margaret E. Ackerman
Current Opinion in HIV and AIDS (2020) Vol. 15, Iss. 5, pp. 282-289
Open Access | Times Cited: 14
Differential V2-directed antibody responses in non-human primates infected with SHIVs or immunized with diverse HIV vaccines
Svenja Weiß, Vincenza Itri, Ruimin Pan, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study
Avi Kenny, Janine van Duijn, One Dintwe, et al.
EBioMedicine (2024) Vol. 108, pp. 105320-105320
Closed Access | Times Cited: 1
Signal peptide exchange alters HIV-1 envelope antigenicity and immunogenicity
Chitra Upadhyay, P. S. Rao, Mohammad Amin Behzadi, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Effects of persistent modulation of intestinal microbiota on SIV/HIV vaccination in rhesus macaques
Nichole R. Klatt, Courtney A. Broedlow, Jessica M. Osborn, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 12
Rapid Induction of Multifunctional Antibodies in Rabbits and Macaques by Clade C HIV-1 CAP257 Envelopes Circulating During Epitope-Specific Neutralization Breadth Development
Delphine C. Malherbe, Constantinos Kurt Wibmer, Molati Nonyane, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 12
An HIV Vaccine Targeting the V2 Region of the HIV Envelope Induces a Highly Durable Polyfunctional Fc-Mediated Antibody Response in Rhesus Macaques
Rebecca Powell, Svenja Weiß, Alisa Fox, et al.
Journal of Virology (2020) Vol. 94, Iss. 17
Open Access | Times Cited: 10
A High Through-put Assay for Circulating Antibodies Directed against the S Protein of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Svenja Weiß, Jéromine Klingler, Catarina E. Hioe, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 9
Virus Control in Vaccinated Rhesus Macaques Is Associated with Neutralizing and Capturing Antibodies against the SHIV Challenge Virus but Not with V1V2 Vaccine–Induced Anti-V2 Antibodies Alone
Ann J. Hessell, Liuzhe Li, Delphine C. Malherbe, et al.
The Journal of Immunology (2021) Vol. 206, Iss. 6, pp. 1266-1283
Open Access | Times Cited: 9
Antibodies from Rabbits Immunized with HIV-1 Clade B SOSIP Trimers Can Neutralize Multiple Clade B Viruses by Destabilizing the Envelope Glycoprotein
Marlies M. van Haaren, Laura E. McCoy, Jonathan L. Torres, et al.
Journal of Virology (2021) Vol. 95, Iss. 17
Open Access | Times Cited: 9
Mucosal Delivery of HIV‐1 Glycoprotein Vaccine Candidate Enabled by Short Carbon Nanotubes
Yang Xu, Xunqing Jiang, Ziyou Zhou, et al.
Particle & Particle Systems Characterization (2022) Vol. 39, Iss. 5
Open Access | Times Cited: 6
Immune Complex Vaccine Strategies to Combat HIV-1 and Other Infectious Diseases
Alex Tang, Gospel Enyindah-Asonye, Catarina E. Hioe
Vaccines (2021) Vol. 9, Iss. 2, pp. 112-112
Open Access | Times Cited: 7
Structurally related but genetically unrelated antibody lineages converge on an immunodominant HIV-1 Env neutralizing determinant following trimer immunization
Safia Aljedani, Tyler Liban, Karen Tran, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 9, pp. e1009543-e1009543
Open Access | Times Cited: 7
Priming with DNA Expressing Trimeric HIV V1V2 Alters the Immune Hierarchy Favoring the Development of V2-Specific Antibodies in Rhesus Macaques
Santhi Devasundaram, Margherita Rosati, Antonio Valentin, et al.
Journal of Virology (2020) Vol. 95, Iss. 2
Open Access | Times Cited: 7
Direct intranodal tonsil vaccination with modified vaccinia Ankara vaccine protects macaques from highly pathogenic SIVmac251
Jeffy George, Asisa Volz, Olusegun O. Onabajo, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top